Skip to main content

Focus on: FAIRified data


When it comes to big data, no other industry has as much at stake as the biopharmaceutical sector. Data from sources like health records, imaging, genome sequencing and wearables are potentially very valuable, and could drive massive improvements in European health systems. Making this data FAIR (findable, accessible, interoperable and reusable) is a simple message with wide appeal to researchers who spend an inordinate amount of time finding, processing, organising and curating data. 

Read more 

The story so FAIR

From a few clicks to a few months - FAIRified datasets can fast-track drug development

More and better patients data, whatever the disease

Manage your newsletter subscriptions
Stay informed - subscribe to our newsletter.